Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVACO varenicline plus counselling for smoking cessation
2009-016446-50Phase 4Active
- Sponsor
- Maastricht University
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Maastricht University. Primary endpoint: Prolonged smoking abstinence week 9–26 (CO-validated). Started Nov 2009; status: active.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2009-016446-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016446-50.